Trial of AD113 and Atomoxetine in OSA Patients With Hypertension
Study sponsor: Apnimed
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-01-31Actual
Enrollment · participants21Actual
Source updated2023-08-21Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.